DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20181675

Association between vitamin D level and patients with cholestasis

Manal M. Anwar, Ahmed E. Arafa, Dalia S. Morgan, Khaled K. Mohamed

Abstract


Background: Estimate the prevalence of vitamin D deficiency among patients diagnosed with chronic cholestasis and investigates the association between their clinical manifestations and lab results of 25(OH) D levels.

Methods: A cross sectional study of 50 patients aged > 3 months up to 18 years, who had medical care in the Beni-Suef University hospital, Beni-Suef governorate, Egypt. All patients were fully investigated including routine labs in addition to 25- [OH] D levels and dual energy X-ray absorptiometry (DXA).

Results: Mean age was 6.5±4.5 years. Mean serum 25 (OH) D levels was 37.9±28.2; 30% of patients had 25 (OH) D <20 ng/ml and 26% had 25 (OH) D 20-<30 ng/ml. Low BMD was diagnosed in 73.1% of patients. The spine DXA BMD ranged between -5.4 and -1.4 (-2.9±0.9 Z-scores). A delayed milestone was reported in 32% of patients, and 56% had signs of rickets.

Conclusions: Deficiency of Vitamin D, signs of rickets and osteoporosis were evident in chronic cholestasis patients. No statistical significance was detected between 25- D [OH] levels and clinical, laboratory and radiological findings.


Keywords


Cholestasis, Vitamin D, Deficiency, Osteoporosis, BMD

Full Text:

PDF

References


Strople J, Lovell G, Heubi J. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease. J Pediatr Gastroenterol Nutr. 2009;49:78-84.

Hoerning A, Raub S, Dechene A, Brosch MN, Kathemann S, Hoyer PF, et al. Diversity of disorders causing neonatal cholestasis–the experience of a tertiary pediatric center in Germany. Front Pediatr. 2014;2:65.

Feranchak AP, Ramires RO, Sokol RJ. Medical and nutritional management of cholestasis. In: Suchy FJ, Sokol RJ, Balistreri F, editores. Liver disease in children. Filadélfia: Lippincott Williams & Wilkins; 2001: 195-237.

Nguyen KD, Sundaram V, AyoubWS. Atypical causes of cholestasis. World J Gastroentero. 2014;20:9418-26

Barches NR, Chang I, Karpen SJ, Carter BA, Goss JA. Impact of pretransplant growth retardation in pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2006;43:89-94.

Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007;5:513-20.

Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-76.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2011;10:482-96.

Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;7;376:180-8.

Vogel A, Strassburg C, Mannas M. Genetic association of vitamin D receptor polymorphism with primary biliary cirrhosis and autoimmune hepatitis. Hepatol 2002;35:126-31.

Kapil U, Goindi G. Vitamin A supplementation to children in India from controversies to consensus. J Trop Pediatr. 2004;50:311-2.

Wang LJE, Manson Y, Song HD. Seasso,. Systematic review, vitamin D and calcium supplementation in prevention of cardiovascular events. Annals of Int Med. 2010;152:315-23.

Heubi JE, Hollis BW, Specker B, Tsang RC. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology. 1989;9:258-64.

Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-73.

Nair S. Vitamin D Deficiency and Liver Disease. Advances in Hepatology. Gastroenterol Hepatol. 2010;6:491-93.

Mohammadi B, Najafi M, Farahmand F, Motamed F,Ghajarzadeh M, Mohammadi J, and Roze EM. Prevalence of Vitamin D Deficiency and Rickets in Children with Cholestasis in Iran. Acta Medica Iranica. 2012;50:483-5.

Talaat AA, El Raziky MS, Haroun MS, Salama HM, El Tookhy S. and Hasanein HM. Bone Mineral Status in Children WithCholestatic Liver Diseases. Australian J Basic Applied Sci. 2011;5:306-311.

Hutchin, T., M.A. Preece, C. Hendriksz, et al. neonatal intra-hepatic Cholestasis caused by citrineeficiency (NICCD) as a cause of liver disease in infants. J Inherits Metab Dis. 2009;16:144-152.

Bastos M, Da Silveira T. Blood levels of vitamin Din children and adolescents with chronic cholestasis. Jornal de Pediatria. 2003;79:3.

Holick MF. Vitamin D deficiency. N Eng J Med. 2007;357:266-281.

Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int. 2013;33:338-52.

Ogura M, Nishida S, Ishizawa M. Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct ligated mice. J Pharmacol Exp Ther. 2009;328:564-70.

Firrincieli D, Zuniga S, Rey C. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice. Hepatology. 2013;58:1401-12.

Heuman DM, Mihas AA, Habib A. MELD-XI: a rational approach to "sickest first" livertransplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13:30-7.

Guañabens N, Parés A, Ros I, Caballería L, Pons F, Vidal S, et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol. 2005;42:573–7.

Chongsrisawat V, Rottanamongkol P, Chaiwatanarat T, Chandrakamol B, Poovorawan Y. Bone density and 25- hydroxyvitamin D level in extrahepatic biliary atresia. Pediatr Surg Int 2001;17:604-8.

Gasser RW. Cholestasis and metabolic bone disease - a clinical review. Wien Med Wochenschr. 2008;158:553–7.

Schiefke I, Fach A, Wiedmann M, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005;11:1843–7.

Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42:423–9.

González-Reimers E, Alvisa-Negrín J, Santolaria-Fernandez F. Prognosis of osteopenia in chronic alcoholics. Alcohol. 2011;45:227–38.

Guggenbuhl P, Fergelot P, Doyard M. Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int. 2011;22:2313–9.

Rueda Adel C, Grande NC, Fernández EA, Enríquez de Salamanca R, Sala LA, Jiménez MJ. Mutations in HFE and TFR2 genes in a Spanish patient with hemochromatosis. Rev Esp Enferm Dig. 2011;103:379–82.